345 related articles for article (PubMed ID: 7407790)
1. Designing for cancer clinical trials: selection of prognostic factors.
Brown BW
Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
[TBL] [Abstract][Full Text] [Related]
2. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial.
Weir CJ; Lees KR
Stat Med; 2003 Mar; 22(5):705-26. PubMed ID: 12587101
[TBL] [Abstract][Full Text] [Related]
3. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
Byar D; Chastang C
Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
[TBL] [Abstract][Full Text] [Related]
4. Allocation of patients to treatment in clinical trials.
Pocock SJ
Biometrics; 1979 Mar; 35(1):183-97. PubMed ID: 497334
[TBL] [Abstract][Full Text] [Related]
5. Patient heterogeneity in clinical trials.
Simon R
Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777
[TBL] [Abstract][Full Text] [Related]
6. [Randomization for controlled therapeutic trials].
Schemper M
Wien Klin Wochenschr; 1982 Nov; 94(22):604-9. PubMed ID: 7164464
[TBL] [Abstract][Full Text] [Related]
7. Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research.
Müller MJ; Scheurich A; Wetzel H; Szegedi A; Hautzinger M
Alcohol Alcohol; 2005; 40(2):124-31. PubMed ID: 15642723
[TBL] [Abstract][Full Text] [Related]
8. Maximum entropy constrained balance randomization for clinical trials.
Klotz JH
Biometrics; 1978 Jun; 34(2):283-7. PubMed ID: 352415
[TBL] [Abstract][Full Text] [Related]
9. Randomization procedures in orthopaedic trials.
Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
[TBL] [Abstract][Full Text] [Related]
10. Statistical comparison of random allocation methods in cancer clinical trials.
Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
Control Clin Trials; 2004 Dec; 25(6):572-84. PubMed ID: 15588744
[TBL] [Abstract][Full Text] [Related]
11. Designs for experiments--parallel comparisons of treatment.
Lavori PW; Louis TA; Bailar JC; Polansky M
N Engl J Med; 1983 Nov; 309(21):1291-9. PubMed ID: 6633587
[TBL] [Abstract][Full Text] [Related]
12. [Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].
Mollié A; Hill C
Rev Epidemiol Sante Publique; 1988; 36(2):138-43. PubMed ID: 3045921
[TBL] [Abstract][Full Text] [Related]
13. Design and analysis of prostate cancer trials.
Sylvester R
Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for randomization and stratification and endpoints for the evaluation of trials.
Sylvester RJ; Suciu S; Yamanaka H
Prog Clin Biol Res; 1988; 269():275-87. PubMed ID: 3293065
[No Abstract] [Full Text] [Related]
15. Randomization by minimization for unbalanced treatment allocation.
Han B; Enas NH; McEntegart D
Stat Med; 2009 Nov; 28(27):3329-46. PubMed ID: 19739238
[TBL] [Abstract][Full Text] [Related]
16. Minimization method for balancing continuous prognostic variables between treatment and control groups using Kullback-Leibler divergence.
Endo A; Nagatani F; Hamada C; Yoshimura I
Contemp Clin Trials; 2006 Oct; 27(5):420-31. PubMed ID: 16807130
[TBL] [Abstract][Full Text] [Related]
17. Trends in the application of dynamic allocation methods in multi-arm cancer clinical trials.
Pond GR; Tang PA; Welch SA; Chen EX
Clin Trials; 2010 Jun; 7(3):227-34. PubMed ID: 20406744
[TBL] [Abstract][Full Text] [Related]
18. New algorithm for treatment allocation reduced selection bias and loss of power in small trials.
Hofmeijer J; Anema PC; van der Tweel I
J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784
[TBL] [Abstract][Full Text] [Related]
19. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
Atkinson AC; Biswas A
Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
[TBL] [Abstract][Full Text] [Related]
20. Studies with group treatments required special power calculations, allocation methods, and statistical analyses.
Faes MC; Reelick MF; Perry M; Olde Rikkert MG; Borm GF
J Clin Epidemiol; 2012 Feb; 65(2):138-46. PubMed ID: 21856120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
